RIKER LABORATORIES INC innovation strategy

Patent filings in countries

#	Country	Total Patents
#1	United States	253
#2	Canada	98
#3	Australia	81
#4	United Kingdom	72
#5	Japan	71
#6	EPO (European Patent Office)	65
#7	France	50
#8	South Africa	50
#9	Denmark	45
#10	New Zealand	45
#11	Norway	40
#12	Germany	37
#13	Israel	37
#14	Spain	32
#15	Ireland	29
#16	Sweden	27
#17	WIPO (World Intellectual Property Organization)	25
#18	Republic of Korea	20
#19	Switzerland	19
#20	Netherlands	18
#21	Belgium	16
#22	Italy	15
#23	Finland	12
#24	Austria	10
#25	Portugal	9
#26	Czechoslovakia	8
#27	Hong Kong	8
#28	Argentina	7
#29	Greece	5
#30	Mexico	5
#31	Brazil	4
#32	African Intellectual Property Organization	4
#33	India	3
#34	Philippines	3
#35	Poland	3
#36	Czechia	2
#37	German Democratic Republic	2
#38	Egypt	2
#39	Hungary	2
#40	USSR (Union of Socialist Soviet Republics)	2
#41	China	1
#42	Luxembourg	1
#43	Russian Federation	1
#44	Singapore	1
#45	Slovakia	1

#	Industry
#1	Organic fine chemistry
#2	Pharmaceuticals
#3	Medical technology
#4	Machines
#5	Basic materials chemistry
#6	Macromolecular chemistry and polymers
#7	Packaging and shipping

#	Technology
#1	Heterocyclic compounds
#2	Therapeutic chemical compounds
#3	Acyclic or carbocyclic compounds
#4	Medical preparations
#5	Syringes
#6	Unspecified technologies
#7	Preservation of human bodies
#8	Polysaccharides
#9	Containers for goods storage
#10	Object sterilising

#	Name	Total Patents
#1	Scherrer Robert A	72
#2	Gerster John F	49
#3	Moore George G I	46
#4	Stern Richard M	45
#5	Wade James J	32
#6	Rustad Mark A	26
#7	Scherrer Robert Allan	26
#8	Banitt Elden H	25
#9	Thiel Charles G	24
#10	Wass Anthony Charles Lammond	23

Publication	Filing date	Title
HK1006545A1	1998-06-19	Transdermal estradiol delivery system
US5776434A	1997-01-16	Medicinal aerosol formulations
US5756747A	1995-05-31	1H-imidazo 4,5-c!quinolin-4-amines
US5750136A	1995-05-31	Bioadhesive composition and patch
US5750134A	1995-05-31	Bioadhesive composition and patch
US5736553A	1995-05-31	Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo 4,5-C!quinolin-4-amine
US5439670A	1993-07-02	Medicinal aerosol formulations
NZ242478A	1992-04-24	Aqueous pharmaceutical suspension for oral administration comprising particulate medicament which remains uniformly suspended for an extended period of time
IE921317A1	1992-04-23	Oral suspension formulation
US5238944A	1992-03-03	Topical formulations and transdermal delivery systems containing 1-isobutyl-1H-imidazo[4,5-c]quinolin-4-amine
US5223261A	1991-12-31	Transdermal estradiol delivery system
US5166343A	1991-11-05	Triazolo[1,5-c]pyrimido[1,4]-azines as bronchodilators
US5237070A	1991-05-16	Substituted DI-t-butylphenols
US5103037A	1991-05-13	Substituted di-t-butylphenols
NZ237645A	1991-03-28	Flexible sheet material comprising uniform sized depressions containing
US5225183A	1991-01-30	Medicinal aerosol formulations
JPH04193866A	1990-11-28	Preparation of 1h-imidazo(4,5-c)quinoline
GB9025654D0	1990-11-26	Device
NZ236165A	1990-11-20	Mucosal bioadhesive compositions
GB9024760D0	1990-11-14	Inhalation device and medicament carrier